How long do families wait for Ontario autism services?
Ontario autism wait times for core clinical services now exceed **5+ years** (2026). Most families currently receiving invitations registered in 2020 or earlier. This delay far exceeds the sensitive early intervention window recommended by developmental specialists. [FAO]
Source: OAC FOI Mar 2026, FAO Report 2024
Public information
Direct answer
Quick Answer
Sleep Issues in Autistic Children: What Helps
Direct answer
Sleep difficulties affect 50-80% of autistic children, compared to 25-40% of neurotypical peers (Richdale & Schreck, 2009). Common issues include delayed sleep onset, night waking, and early morning rising. First-line treatment is behavioural sleep intervention (sleep hygiene, bedtime routines, stimulus fading). Melatonin (0.5-5mg) is the most studied pharmacological option, with a Cochrane review by Rossignol & Frye (2011) showing improved sleep onset latency by an average of 28 minutes.
50-80%
Prevalence in ASD
Richdale & Schreck, 2009
-28 min sleep onset
Melatonin Efficacy
Rossignol & Frye, 2011
First-line treatment
Behavioural Approach
AAP, 2020
FOI & Government Data
Last verified: March 4, 2026Sources: FAO Report 2023-24 (Financial Accountability Office of Ontario) · 2026 Ontario Budget (tabled March 26, 2026) · CBC News FOI investigation — bi-weekly OAP progress reports, Jun 2024 – Jan 2026, published Mar 30, 2026 (Nicole Brockbank & Angelina King) · MCCSS bi-weekly OAP Core Clinical Services progress reports, Dec 10, 2025 – Mar 4, 2026, obtained under Freedom of Information (release CSS2026-0749)
Sleep Issues in Autistic Children: What Helps
Prevalence in ASD: 50-80% (Richdale & Schreck, 2009)
Melatonin Efficacy: -28 min sleep onset (Rossignol & Frye, 2011)
Start with the short answer, then reveal deeper context where helpful.
Why Sleep Is Different for Autistic Children
Sleep difficulties in autistic children have both biological and behavioural roots. Research suggests differences in melatonin production and circadian rhythm regulation, sensory sensitivities that interfere with settling, co-occurring anxiety, and difficulty with transitions (including the transition from wakefulness to sleep). Richdale & Schreck (2009) found that 50-80% of autistic children experience clinically significant sleep problems.
Poor sleep has cascading effects: increased daytime challenging behaviours, reduced learning capacity, worsened sensory sensitivities, and significant family stress. Parents of autistic children with sleep problems report higher rates of caregiver burnout and mental health difficulties. Addressing sleep is therefore a high-priority intervention target.
Treatment Approaches
The American Academy of Pediatrics recommends behavioural sleep interventions as first-line treatment. These include: consistent bedtime routines, sleep hygiene optimization (dark room, cool temperature, screen removal 60+ minutes before bed), graduated extinction or stimulus fading techniques, and visual schedules for the bedtime sequence. BCBAs and psychologists can design individualized behavioural sleep programs.
When behavioural approaches alone are insufficient, melatonin is the most-studied pharmacological intervention. A Cochrane-style review by Rossignol & Frye (2011) found melatonin reduced sleep onset latency by an average of 28 minutes and increased total sleep time by approximately 48 minutes. Dosing typically ranges from 0.5-5mg, 30 minutes before desired bedtime. Consult your child's physician before starting melatonin or any medication.
Why Sleep Is Different for Autistic Children
Sleep difficulties in autistic children have both biological and behavioural roots. Research suggests differences in melatonin production and circadian rhythm regulation, sensory sensitivities that interfere with settling, co-occurring anxiety, and difficulty with transitions (including the transition from wakefulness to sleep). Richdale & Schreck (2009) found that 50-80% of autistic children experience clinically significant sleep problems.
Poor sleep has cascading effects: increased daytime challenging behaviours, reduced learning capacity, worsened sensory sensitivities, and significant family stress. Parents of autistic children with sleep problems report higher rates of caregiver burnout and mental health difficulties. Addressing sleep is therefore a high-priority intervention target.
Treatment Approaches
The American Academy of Pediatrics recommends behavioural sleep interventions as first-line treatment. These include: consistent bedtime routines, sleep hygiene optimization (dark room, cool temperature, screen removal 60+ minutes before bed), graduated extinction or stimulus fading techniques, and visual schedules for the bedtime sequence. BCBAs and psychologists can design individualized behavioural sleep programs.
When behavioural approaches alone are insufficient, melatonin is the most-studied pharmacological intervention. A Cochrane-style review by Rossignol & Frye (2011) found melatonin reduced sleep onset latency by an average of 28 minutes and increased total sleep time by approximately 48 minutes. Dosing typically ranges from 0.5-5mg, 30 minutes before desired bedtime. Consult your child's physician before starting melatonin or any medication.
Frequently asked questions
Melatonin has a strong safety profile in short-to-medium term studies (Rossignol & Frye, 2011). It is available over-the-counter in Canada. Start with the lowest effective dose (0.5-1mg) 30 minutes before bedtime. Long-term effects are less studied. Always consult your child's physician before starting any supplement.
Yes. BCBAs can design behavioural sleep interventions including structured bedtime routines, graduated extinction, and stimulus fading. These approaches address the behavioural components of sleep difficulties and are eligible for <a href="/oap-funding-guide" class="text-blue-600 hover:underline font-medium">OAP funding</a> as part of a behaviour plan.
See a sleep specialist if behavioural approaches and melatonin are not sufficient, if you suspect sleep apnea (snoring, breathing pauses), if your child has extreme difficulty falling or staying asleep despite consistent intervention, or if daytime functioning is significantly impaired.
Sources
1
Research
Richdale & Schreck (2009), "Sleep Problems in Autism: Prevalence, Nature, and Possible Biopsychosocial Aetiologies," Sleep Medicine Reviews, 13(6), 403-411
2
Research
Rossignol & Frye (2011), "Melatonin in ASD: A Systematic Review and Meta-Analysis," Developmental Medicine & Child Neurology, 53(9), 783-792
Commitment to Accuracy: Our data is verified against official government reports (FAO, MCCSS), peer-reviewed scientific literature, and accessible public records. Last updated: March 24, 2026.
Next Steps
Next Steps
These statistics represent real children missing their critical developmental windows.